Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis

Approximately, 10–20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guozhong, Zhao, Quanming, Chen, Qing, Zhang, Xiaoxia, Tian, Lei, Zhang, Xiaojiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
PCI
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791562/
https://www.ncbi.nlm.nih.gov/pubmed/31464729
http://dx.doi.org/10.1097/MCA.0000000000000784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791562/
https://www.ncbi.nlm.nih.gov/pubmed/31464729
http://dx.doi.org/10.1097/MCA.0000000000000784

Ejemplares similares